A detailed history of Wellington Management Group LLP transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Wellington Management Group LLP holds 288,813 shares of AVXL stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
288,813
Previous 194,921 48.17%
Holding current value
$1.05 Million
Previous $1.8 Million 43.02%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$8.44 - $13.41 $792,448 - $1.26 Million
93,892 Added 48.17%
288,813 $2.57 Million
Q2 2025

Aug 14, 2025

BUY
$7.37 - $9.63 $58,377 - $76,279
7,921 Added 4.24%
194,921 $1.8 Million
Q1 2025

May 13, 2025

BUY
$7.85 - $13.46 $1.47 Million - $2.52 Million
187,000 New
187,000 $1.6 Million
Q4 2024

Feb 12, 2025

BUY
$5.11 - $12.56 $810,824 - $1.99 Million
158,674 New
158,674 $1.7 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $284M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.